Disclaimer for the US market

The products and information provided on this website are intended for healthcare professionals. These products are not for sale or distribution in the United States and statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). The efficacy of these products has not been confirmed by FDA-approved research and these products are therefore not intended to diagnose, treat, cure or prevent any disease. All information presented here is for general information purposes only and not meant as a substitute for or alternative to advice from healthcare practitioners. The Federal Food, Drug and Cosmetic Act requires this notice.

Neither the Company nor its representatives is providing any medical advice, and none should be inferred, from any ideas, suggestions, testimonials or other information set forth on this website or in other Company materials or provided over the phone, in the mail, in product packaging, or in email correspondence. This website may contain links to third-party websites. The Company provides these links as a convenience only and does not endorse any of these sites. The Company is not responsible for the content of, and does not make any representations regarding the materials on, such linked third-party websites. If you decide to access or rely on information at linked third-party website, you do so at our own risk. Our terms and conditions, including disclaimers, are more fully set forth in our Terms of Use, Privacy Policy and Terms of Online Sales.

The CARL-Mobil in the rescue chain of Freiburg

When an emergency call is received at the integrated control center in Freiburg and a cardiac arrest, a secured resuscitation or a drowning accident is reported, the CARL-Mobil is alerted directly in addition to an ambulance and an emergency medical service vehicle. The concept of parallel alerting thus saves valuable minutes and shortens the time until the arrival of the treatment team.

The CARL-Mobil in Freiburg is an emergency vehicle specialized in extracorporeal resuscitation. On board are two doctors, a perfusionist, an emergency paramedic, and CARL. The aim is to use CARL Technology to increase the chances of survival for people who suffer a cardiac arrest and to prevent neurological sequelae.

An insight into the CARL-Mobil

The CARL-Mobil Team is alerted from the daily hospital routine and meets directly in front of the University Emergency Center of the Medical Center – University of Freiburg. On average, it takes about 12 minutes after an alert to arrive at the scene in the Freiburg city area. In addition to the CARL-Mobil Team, emergency paramedics, paramedics and an emergency physician are also on site during a resuscitation. Upon arrival at the scene, the CARL Team and the attending emergency physician decide whether extracorporeal resuscitation is indicated based on the information available about the patient and the overall situation. The CARL Team is trained in the use of CARL Technology to provide the best possible CARL therapy. CARL is safely stowed in the ambulance: it is positioned on the CARL Rack, which is attached to the foot end of the patient stretcher.

When the patient’s condition is sufficiently stabilized, he is transferred to the Medical Center – University of Freiburg. There, further treatment takes place either directly in the intensive care unit, in the shock room or in the cardiac catheterization laboratory, depending on the suspected cause of the circulatory arrest. In order to optimize the acute in-hospital care of resuscitated patients in the Cardiac Arrest Center, an interdisciplinary reception team, the Cardiac Arrest Receiving Team (CART), was formed at Medical Center – University of Freiburg. This team is composed of staff from intensive care medicine and acute and emergency medicine and coordinates the transfer of the patient to the in-hospital care chain.


< Zurück